Antibodies having specificity for BTN2 and uses thereof
US12258400B2 · kind B2 · utility
0Cited by
0References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 20, 2020 |
| Grant date | Mar 25, 2025 |
| Priority date | — |
| Expiry date | Jul 25, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to antibodies having specificity for BTN2A and uses thereof, in particular for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.